Standout Papers

Combination strategies with PD-1/PD-L1 blockade: current advances and future directions 2022 2026 2023 2024827
  1. Combination strategies with PD-1/PD-L1 blockade: current advances and future directions (2022)
    Ming Yi, Xiaoli Zheng et al. Molecular Cancer

Immediate Impact

1 by Nobel laureates 3 from Science/Nature 56 standout
Sub-graph 1 of 22

Citing Papers

Ultrasound-Based Micro-/Nanosystems for Biomedical Applications
2024 Standout
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2024 Standout
3 intermediate papers

Works of Hong Ge being referenced

Combination strategies with PD-1/PD-L1 blockade: current advances and future directions
2022 Standout
Co-expression of EGFRvIII with ErbB-2 enhances tumorigenesis: EGFRvIII mediated constitutively activated and sustained signaling pathways, whereas EGF-induced a transient effect on EGFR-mediated signaling pathways
2008
and 1 more

Author Peers

Author Last Decade Papers Cites
Hong Ge 492 308 824 602 104 1.9k
Dawei Chen 856 224 1384 463 84 2.2k
C. Norman Coleman 509 394 526 460 51 1.7k
Christopher D. Willey 507 180 767 1217 116 2.4k
Takahiro Oike 722 301 1235 1303 113 2.8k
Deepa S. Subramaniam 775 221 897 789 78 2.2k
Paul B. Romesser 831 383 919 633 110 2.6k
Aurélie Bertaut 563 159 809 351 101 1.7k
Nicholas H. A. Terry 550 446 639 850 87 2.3k
Marie‐Christine Mathieu 386 399 960 454 63 2.0k
Jung Shin Lee 522 117 541 583 86 1.7k

All Works

Loading papers...

Rankless by CCL
2026